๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pathogenic role of glial cells in Parkinson's disease

โœ Scribed by Peter Teismann; Kim Tieu; Oren Cohen; Dong-Kug Choi; Du Chu Wu; Daniel Marks; Miquel Vila; Vernice Jackson-Lewis; Serge Przedborski


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
98 KB
Volume
18
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

An erratum for this article appears in the January, 2004 issue of Movement Disorders (Mov Disord 2004;19:119).

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of proโ€oxidant reactive species, and proโ€inflammatory prostaglandin and cytokines. We discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how those factors may contribute to the pathogenesis of this disease. ยฉ 2002 Movement Disorder Society


๐Ÿ“œ SIMILAR VOLUMES


Clarification: Pathogenic role of glial
โœ Serge Przedborski ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 26 KB

## Abstract The original article to which this Clarification refers was published in the February 2003 issue of __Movement__ Disorders (Teismann P, Tieu K, Cohen O, Choi DK, Wu dC, Marks D, Vila M, Jacksonโ€Lewis V, Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov Disord 200

Glial reactions in Parkinson's disease
โœ Patrick L. McGeer; Edith G. McGeer ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB

## Abstract Dopaminergic neurons of the substantia nigra are particularly vulnerable to oxidative and inflammatory attack. Such processes may play a crucial role in the etiology of Parkinson disease (PD). Since glia are the main generators of these processes, the possibility that PD may be caused b

Hippocampal neuron and glial cell number
โœ F.C. Joelving; R. Billeskov; J.R. Christensen; M. West; B. Pakkenberg ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 217 KB ๐Ÿ‘ 1 views

Hippocampal atrophy and neuron loss are early and reproducible findings in Alzheimer's disease, and recent magnetic resonance imaging studies indicate that hippocampal atrophy may also be present in Parkinson's disease (PD). To determine whether or not cell loss occurs in PD, we estimated the total

In vivo gene delivery of glial cell line
โœ Jeffrey H. Kordower ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 564 KB

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects approximately 1,000,000 Americans. The cause of the disease remains unknown. The histopathological hallmarks of the disease are dopaminergic striatal insufficiency secondary to a loss of dopaminergic neurons in the sub

Role of glial cells in cerebral ischemia
โœ Maiken Nedergaard; Ulrich Dirnagl ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 223 KB

## Abstract Despite intense efforts at the bench and at the bedside, few therapeutic strategies exist to combat the consequences of cerebral ischemia. Traditionally, a โ€œneurocentricโ€ view has dominated research in this field. Evidence is now accumulating that glial cells, in particular astrocytes,